Registration for the 2005 Midwest Pharmaceutical Process Chemistry Consortium is now closed. Thanks for your interest and participation.
Presentations From the 2005 Event
- Dr. Michael Lipton, Pfizer Global R&D
An Asymmetric Synthesis on Scale - Dr. Eric Moher, Eli Lilly and Company
Synthesis Studies on a Conformationally Restricted Glutamic Acid Analog - Dr. Kevin Henegar, Pfizer Global R&D
Development of Processes for the Synthesis of (+/-) and S,S-Reboxetine - Dr. Nick Magnus, Eli Lilly and Company
Development of a Mild b-Ketonitrile Knorr Reaction to Afford an AMPA Potentiator - Mr. David Boyles & Mr. Derek Vrieze, Pfizer Global R&D
Initial Scale-up of Pyrrolidine Side-chain and Two Quinazolinediones: Two Novel Core
Structures as Anti-Infectives - Dr. Robert Appell, Dowpharma
A Scalable Process to Pharmaceutically-Useful Cyclobutanones - Dr. Matt Ravn, Abbott Laboratories
ABT-737 - Early Scale Up Experience - Dr. Robert Wade & Dr. Vladimir Beylin
Automation Technology and Process Development
Schedule of events
| Thursday Sept. 29, 2005 | |
| 8am – 2pm | Golf outing sponsored by SAFC Pharma |
| 2pm – 5pm | Tours of Ann Arbor High Pressure Lab and Kilo Lab (requires pre-registration) |
| 5pm – 7pm | Round Table Discussions
Dr. John VanAlsten, Pfizer Global R&D, discussion leader "Continuous |
| 6:30pm – 8:30pm | Speaker’s Dinner (by invitation) Opening remarks |
| 7pm –10:30pm | Poster session & mixer |
| Friday Sept. 30, 2005 | |
| 8:15am | Opening remarks Dr. Daniel Belmont, Senior Director, Michigan Chemical Research and Development |
| Session 1: | Chair - Dr. Bill Kissel, Pfizer Global R&D |
| 8:30-9:15 | Dr. Michael Lipton, Pfizer Global R&D An Asymmetric Synthesis on Scale |
| 9:15-9:40 | Dr. Eric Moher, Eli Lilly and Company Synthesis Studies on a Conformationally Restricted Glutamic Acid Analog |
| 9:40-10:10 | Break |
| Session 2 | Chair - Dr. Tim Curran, Pfizer Global R&D |
| 10:10-10:55 | Dr. Kevin Henegar, Pfizer Global R&D Development of Processes for the Synthesis of (+/-) and S,S-Reboxetine |
| 10:55-11:20 | Dr. Nick Magnus, Eli Lilly and Company Development of a Mild b-Ketonitrile Knorr Reaction to Afford an AMPA Potentiator |
| 11:20-11:45 | Mr. David Boyles & Mr. Derek Vrieze, Pfizer Global R&D Initial Scale-up of Pyrrolidine Side-chain and Two Quinazolinediones: Two Novel Core Structures as Anti-Infectives |
| 11:45-1:15 | Lunch |
| Session 3: | Chair - Dr. Zhijian Zhu, Pfizer Global R&D |
| 1:15-2:00 | Dr. Robert Appell, Dowpharma A Scalable Process to Pharmaceutically-Useful Cyclobutanones |
| 2:00-2:45 | Dr. Matt Ravn, Abbott Laboratories ABT-737 - Early Scale Up Experience |
| 2:45-2:50 | Closing remarks Dr. Jerry Clark, Associate Director, Pfizer Global R&D |